News
Bank of America Securities analyst Mariana Perez Mora maintained a Hold rating on V2X (VVX – Research Report) today and set a price target of ...
RESTON, Va., April 17, 2025 /PRNewswire/ -- V2X, Inc., (NYSE: VVX), a leading provider of global mission solutions, will report first quarter 2025 financial results ...
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective increased by Bank of America from $555.00 to $567.00 in a research note issued on Monday,Benzinga reports.
V2X develops, integrates, and sustains mission-critical weapon system capabilities to enhance combat readiness across airborne platforms. V2X delivers secure, platform-agnostic Weapon System ...
If you’re unfamiliar with V2X, it was created through the July 5, 2022, reverse merger of publicly-traded Vectrus Inc. and privately-owned The Vertex Company. The combination created a company ...
“Seeing that Jolt Capital’s long time Singaporean partner Vertex Growth is now joining the Dolphin Semiconductor’s journey is wonderful news indeed. As we are solidifying the company’s presence in ...
The new ChargePoint technology designed for consumers in North America and Europe will enable vehicle-to-everything (V2X) capabilities and the ability to charge your EV in as quickly as four hours.
RESTON, Va., April 7, 2025 /PRNewswire/ -- V2X (NYSE: VVX) will highlight its latest readiness innovations at the 2025 Sea-Air-Space Exposition, hosted by the Navy League of the United States, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results